Table 1.
Characteristics of patients receiving hemodialysis (HD).
| Number (n) | 107 |
| Female (%) | 31.5 |
| Age (years) | 65.1 ± 14.3 |
| BMI (kg/m2) | 28.4 ± 7.5a |
| Hypertension | 79.4% |
| Systolic blood pressure (mmHg) | 137.7 ± 21.3a |
| Diastolic blood pressure (mmHg) | 73.7 ± 12.3a |
| Hypertensive patients using antihypertensives (%) | 98.1 |
| Patients on beta-blocker (%) | 83.5 |
| Patients on ARBs/ACEi (%) | 63.5 |
| Diabetes type II (%) | 38.3 |
| ICTc treatment (%) | 26.0 |
| Causes of HD | |
| Diabetic and hypertensive kidney disease (%) | 51.4% |
| Chronic glomerulonephritis (%) | 21.5% |
| Polycystic kidney disease (%) | 10.3% |
| Systemic diseased (%) | 5.6% |
| Chronic pyelonephritis (%) | 5.6% |
| Othere (%) | 5.6% |
| Hematocrit % | 0.36 (0.26–0.44)b |
| GFR (mL/min) | 7.3 ± 7.1a |
| Creatinine (µmoL/L) | 745.9 ± 257.4 |
| Urea (mmoL/L) | 22 ± 5.4 |
| Dialysis flow (mL/min) | 300 (105–430)b |
| Plasma flow (mL/min) | 192 (62–275)b |
| Clearance of metanephrines (mL/min) | 78 (22–105)b |
aMean ± standard deviation.
bMedian-range.
cICT intensified insulin treatment.
dSystemic disease: HUS, amyloidosis, multiple myelom, lupus, vasculitis.
eOther: toxicity, medication, kidney tumor, hepatocardiorenal syndrome.